Abstract Aim Convalescent Plasma (CP) therapy is of interest as no vaccine or specific
treatment is available for emerging viruses such as severe acute respiratory syndrome
coronavirus 2 causing Covid-19. It was aimed to report the results of our patients who
underwent CP in the treatment of Covid-19. Methods CP treatment was applied to 26 Covid-
19 patients in intensive care unit who had quantitative reverse transcriptase–polymerase
chain reaction positive Sars-Cov-2 infection. Plasma was collected at least 14 days after …